PubMed Health⌕ Search

Biomedical subjects

I Ia Shakhtmeĭster

Publications and source records attributed to I Ia Shakhtmeĭster.

At least 19 recordsLinked to original sources
PubMed1990

[Vipsogal in the therapy of psoriasis].

A new external drug, vipsogal, manufactured by Galenika, Yugoslavia, was used in therapy of 205 patients suffering from psoriasis. The drug proved to be fairly effective. The authors recommend vipsogal to be included in the complex of drugs used in therapy of psoriasis.

Adult↗
PubMed1990

[Metabolism, vascular tonus and the bone-joint system of psoriasis patients].

A total of 113 patients with disseminated psoriasis were examined. Roentgenograms of the joints have shown signs of osteoarthrosis deformans in 85.7 percent of them. Involvement of the joints of the soles was recorded in 80.5 percent, of the hands in 58.3 percent, of iliosacral articulation in 33.3 percent of patients. These shifts were in line with clinico-laboratory changes characteristic of psoriatic arthropathy in less than one third of the examinees. Rheovasography of the upper and lower limbs has revealed the spastic asthenic syndrome in all the examinees; this syndrome most frequently manifested by increased tone and decreased pulse blood content of the vessels. A direct correlation between x-ray changes in the joints and disordered vascular tone of the limbs has been revealed. The detected elevation of blood lipid level in psoriasis patients as a rule did not correlate with impaired blood supply to the upper and lower limbs. These findings bring the authors to a conclusion that in psoriasis not only the skin, but the bone-and-joint and vascular systems are involved in the process, as are the metabolic processes.

Adolescent↗
PubMed1990

[Voltaren gel in the combined treatment of patients with psoriatic arthritis].

One percent voltaren gel, a new drug manufactured by Ciba-Geigy [correction of Sib-Geigi], Switzerland, was used in the treatment of 57 patients with psoriasis in the progressive stage and psoriatic arthritis symptoms. The drug is characterized by antiinflammatory, analgesic, and antipyretic effects. No side effects or complications were recorded in the course of voltaren gel therapy. The drug has proved highly effective and is recommended for wide practice.

Administration, Topical↗
PubMed1989

[Experience in the use of ditrastic in the therapy of psoriasis].

Forty-six patients suffering from psoriasis have been treated with ditrastic, a new drug for external application, manufactured by Orion, Finland. The drug is manufactured in the form of sticks weighing 2.4 g, containing 1.5 or 3% of dithranol, paraffin, and microcrystalline sulfur. These sticks are applied to psoriatic plaques once daily. The treatment has been effective.

Adolescent↗